Literature DB >> 35546989

Recommendation and Roadmap of Mass Vaccination against Coronavirus Disease 2019 Pandemic in Bangladesh as a Lower-Middle-Income Country.

M J Hossain1, S M A Rahman2, T B Emran3, S Mitra4, M R Islam5, K Dhama6.   

Abstract

Low-income countries (LICs) and lower-middle-income countries (LMICs) are still deprived of the optimum doses of coronavirus disease 2019 (COVID-19) vaccines for their population, equal access and distribution, as well as mass immunization roadmaps to be implemented for achieving herd immunity and protection from the ongoing pandemic. In this short report, we are interacting with the world public health experts, as well as national and global leaders for warranting the mass vaccination drive to be more progressive against COVID-19 with equitable access of vaccines to LICs or LMICs to save the lives of the poorest country people and refugees. From several scientific databases, such as Google Scholar, PubMed, as well as national and international news websites, the data were collected data by utilizing appropriate keywords regarding the topic. Bangladesh might be exemplified in this brief communication as the representative of LMIC. As of October 14, 2021, 48% of the world's people have received at least one dose of the COVID-19 vaccine. In contrast, only 2.5% of people from LICs have come in under COVID-19 vaccination for at least a single shot. Both LICs and LMICs need far more vision and ambition, including political, administrative, and diplomatic progress along with enhancing the vaccination drive for their population to be immunized through simultaneous mass vaccination progress of other countries with implementing public health safety measures against the COVID-19 pandemic.

Entities:  

Keywords:  Bangladesh; COVID-19 outbreak; Lower-middle-income country (LMIC); Successful mass vaccination

Mesh:

Substances:

Year:  2021        PMID: 35546989      PMCID: PMC9083864          DOI: 10.22092/ari.2021.356357.1824

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  37 in total

1.  Acceptance of a vaccine against COVID-19 - a systematic review of surveys conducted worldwide.

Authors:  M Snehota; J Vlckova; K Cizkova; J Vachutka; H Kolarova; E Klaskova; H Kollarova
Journal:  Bratisl Lek Listy       Date:  2021       Impact factor: 1.278

Review 2.  An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.

Authors:  Cielo García-Montero; Oscar Fraile-Martínez; Coral Bravo; Diego Torres-Carranza; Lara Sanchez-Trujillo; Ana M Gómez-Lahoz; Luis G Guijarro; Natalio García-Honduvilla; Angel Asúnsolo; Julia Bujan; Jorge Monserrat; Encarnación Serrano; Melchor Álvarez-Mon; Juan A De León-Luis; Miguel A Álvarez-Mon; Miguel A Ortega
Journal:  Vaccines (Basel)       Date:  2021-04-27

3.  COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic.

Authors:  Khan Sharun; Kuldeep Dhama
Journal:  Arch Med Res       Date:  2021-04-23       Impact factor: 2.235

4.  Herd Immunity to COVID-19.

Authors:  Kamran Kadkhoda
Journal:  Am J Clin Pathol       Date:  2021-01-05       Impact factor: 2.493

Review 5.  Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

Authors:  Olivier J Wouters; Kenneth C Shadlen; Maximilian Salcher-Konrad; Andrew J Pollard; Heidi J Larson; Yot Teerawattananon; Mark Jit
Journal:  Lancet       Date:  2021-02-12       Impact factor: 79.321

6.  Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.

Authors:  Koen B Pouwels; Emma Pritchard; Philippa C Matthews; Nicole Stoesser; David W Eyre; Karina-Doris Vihta; Thomas House; Jodie Hay; John I Bell; John N Newton; Jeremy Farrar; Derrick Crook; Duncan Cook; Emma Rourke; Ruth Studley; Tim E A Peto; Ian Diamond; A Sarah Walker
Journal:  Nat Med       Date:  2021-10-14       Impact factor: 53.440

7.  Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.

Authors:  Khan Sharun; Ruchi Tiwari; Kuldeep Dhama; Talha Bin Emran; Ali A Rabaan; Abbas Al Mutair
Journal:  Hum Vaccin Immunother       Date:  2021-06-23       Impact factor: 3.452

Review 8.  SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Ranjit Sah; Ruchi Tiwari; Mohd Iqbal Yatoo; Shailesh Kumar Patel; Mamta Pathak; Yashpal Singh Malik; Kuldeep Dhama; Karam Pal Singh; D Katterine Bonilla-Aldana; Shafiul Haque; Dayron F Martinez-Pulgarin; Alfonso J Rodriguez-Morales; Hakan Leblebicioglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-02       Impact factor: 3.944

9.  Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic.

Authors:  Abu Montakim Tareq; Talha Bin Emran; Kuldeep Dhama; Manish Dhawan; Trina Ekawati Tallei
Journal:  Hum Vaccin Immunother       Date:  2021-09-02       Impact factor: 3.452

View more
  6 in total

1.  Comparative evaluation of authorized drugs for treating Covid-19 patients.

Authors:  Towhidul Islam; Moynul Hasan; Mohammad Saydur Rahman; Md Rabiul Islam
Journal:  Health Sci Rep       Date:  2022-06-13

2.  Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance.

Authors:  Sohel Daria; Md Rabiul Islam
Journal:  Clin Pathol       Date:  2022-05-18

3.  Increased suicidal behaviors among students during COVID-19 lockdowns: A concern of student's mental health in Bangladesh.

Authors:  Sohel Daria; Md Rabiul Islam
Journal:  J Affect Disord Rep       Date:  2022-02-08

4.  The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far.

Authors:  Md Sohan; Md Jamal Hossain; Md Rabiul Islam
Journal:  J Med Virol       Date:  2022-01-13       Impact factor: 20.693

5.  The Upsurge of Diarrhea Amid COVID-19 Pandemic Makes Matter Worse in Bangladesh: A Call to Action.

Authors:  Smaranika Rahman; Md Jamal Hossain; Md Rabiul Islam
Journal:  Gerontol Geriatr Med       Date:  2022-08-08

6.  Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health.

Authors:  Md Rabiul Islam; Waheeda Nasreen; Ramisa Anjum; Mohammad Shahriar; Arpita Roy; Kuldeep Dhama; Mohiuddin Ahmed Bhuiyan
Journal:  Clin Pathol       Date:  2022-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.